Browse Items (26 total)
- Tags: Bacterial
Nucleotide sequence of a region duplicated in Escherichia coli toc mutants.
Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
Tags: 2004, Amoxicillin-Potassium Clavulanate Combination/*therapeutic use, Anti-Bacterial Agents/pharmacology, Bacteria/drug effects/isolation & purification, Bacterial, Benninger Michael S, Clinics in laboratory medicine, Combination/*therapeutic use, Community-Acquired Infections/drug therapy/microbiology, Department of Internal Medicine, Drug Resistance, Drug Therapy, File Thomas M Jr, Humans, Jacobs Michael R, Microbial Sensitivity Tests, NEOMED College of Medicine, Pneumonia/*drug therapy/microbiology, Sinusitis/*drug therapy/microbiology
Nonresponses and treatment failures with conventional empiric regimens in patients with community-acquired pneumonia.
Overview: Global and Local Impact of Antibiotic Resistance.
Tags: *Agriculture, *Antibiotic resistance, *Bacterial Infections/drug therapy/microbiology/prevention & control, *Drug Resistance, *Global Health, *Infections, *Public health, 2016, Agriculture, Anti-Bacterial Agents/pharmacology/therapeutic use, Bacteria/drug effects, Bacterial, Bonomo Robert A, Department of Internal Medicine, Humans, Infectious disease clinics of North America, NEOMED College of Medicine, United States, Watkins Richard R
Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host.
Tags: *Anti-Bacterial Agents/administration & dosage/pharmacology/therapeutic use, *Bacterial Infections/drug therapy/microbiology, *Drug Resistance, *HIV/AIDS, *Immunocompromise, *Immunocompromised Host, *Infection, *MDRO, *Organ transplant recipients, 2016, Bacteria/drug effects/pathogenicity, Bacterial, Dumford Donald M 3rd, HIV Infections, Humans, Infectious disease clinics of North America, Multiple, Skalweit Marion, Transplant Recipients
The Evolving Role of Antimicrobial Stewardship in Management of Multidrug Resistant Infections.
Tags: *Anti-Bacterial Agents/administration & dosage/therapeutic use, *Antibiotics, *Antimicrobial resistance, *Antimicrobial stewardship, *Drug Resistance, *Medication Therapy Management, 2016, Bacterial, Bacterial Infections/drug therapy, Department of Internal Medicine, File Thomas M Jr, Goff Debra A, Humans, Infectious disease clinics of North America, Multiple, NEOMED College of Medicine
Community-acquired pneumonia.
Tags: *Community-Acquired Infections/diagnosis/drug therapy/microbiology, *Pneumonia, 2003, Adult, Anti-Bacterial Agents/pharmacology/therapeutic use, Bacteria/drug effects/isolation & purification, Bacterial, Bacterial/diagnosis/drug therapy/microbiology, Department of Internal Medicine, Drug Resistance, Female, File Thomas M, Humans, Lancet (London, England), Male, NEOMED College of Medicine
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.
Tags: *Treatment Outcome, 2002, 80 and over, Adolescent, Adult, Aged, Amoxicillin-Potassium Clavulanate Combination/administration & dosage/*pharmacokinetics/pharmacology/*therapeutic use, Amoxicillin/adverse effects/therapeutic use, Bacterial, Bacterial/drug therapy/immunology, Bronchitis/drug therapy/microbiology, Combination/adverse effects/*therapeutic use, Department of Internal Medicine, Double-Blind Method, Drug Administration Schedule, Drug Resistance, Drug Therapy, Female, File Thomas M Jr, Follow-Up Studies, Humans, International journal of antimicrobial agents, Jacobs Michael R, Male, Microbial Sensitivity Tests, Middle Aged, Multicenter Studies as Topic, NEOMED College of Medicine, Pneumonia, Poole Michael D, Respiratory Tract Infections/*drug therapy/metabolism/microbiology, Streptococcal Infections/*drug therapy/metabolism/microbiology, Streptococcus pneumoniae/*drug effects, Wynne Brian
On the path to untreatable infections: colistin use in agriculture and the end of 'last resort' antibiotics.
Tags: *Agriculture, *Antibiotic resistance, *Colistin, *Drug Resistance, 2016, Agriculture, Animal Husbandry, Anti-Bacterial Agents/*therapeutic use, Antibiotics – Therapeutic Use, Bacterial, Bonomo Robert A, Colistin – Analogs and Derivatives, Colistin – Therapeutic Use, Colistin/analogs & derivatives/*therapeutic use, Comparative Studies, Department of Internal Medicine, Drug Resistance, Escherichia coli, Escherichia Coli – Physiology, Escherichia coli Proteins/genetics, Escherichia coli/genetics/*physiology, European Union, Evaluation Research, Expert review of anti-infective therapy, Human, Humans, Microbial, Multicenter Studies, Multiple, NEOMED College of Medicine, Proteins, Smith Tara C, Validation Studies, Watkins Richard R
A formidable foe: carbapenem-resistant Acinetobacter baumannii and emerging nonantibiotic therapies.
Tags: *Carbapenem-resistant Acinetobacter baumannii, *decolonization, *hospital-acquired infections, *therapies, *vaccination, 2018, Acinetobacter baumannii/drug effects/*isolation & purification, Acinetobacter Infections – Microbiology, Acinetobacter Infections – Therapy, Acinetobacter Infections/microbiology/*therapy, Animals, Anti-Bacterial Agents/pharmacology, Antibiotics – Pharmacodynamics, Bacterial, Carbapenems – Pharmacodynamics, Carbapenems/pharmacology, Department of Internal Medicine, Drug Resistance, Expert review of anti-infective therapy, Gram-Negative Aerobic Bacteria, Gram-Negative Aerobic Bacteria – Drug Effects, Humans, Microbial, Microbial Culture and Sensitivity Tests, Microbial Sensitivity Tests, NEOMED College of Medicine, Watkins Richard R
Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs.
Tags: *Drug Resistance, 2011, Anti-Bacterial Agents/administration & dosage/*therapeutic use, Bacterial, Bacterial Infections/*drug therapy/prevention & control, Bacterial/drug therapy, Bacteriuria/drug therapy, Centers for Medicare and Medicaid Services (U.S.), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Community-Acquired Infections/drug therapy, Cosgrove Sara E, Cross Infection/drug therapy, Department of Internal Medicine, Drug Utilization, File Thomas M Jr, Hospitals, Humans, NEOMED College of Medicine, Pneumonia, Practice Guidelines as Topic, Public Health, Quality of Health Care/*standards, Solomkin Joseph S, Surgical Wound Infection/drug therapy, United States
SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
Tags: *clinical trial, *Community-acquired, *Pneumonia, *solithromycin, *Streptococcus pneumoniae, 2016, 80 and over, Administration, Adult, Aged, Anti-Bacterial Agents/*administration & dosage/adverse effects, Bacterial, Bacterial/diagnosis/*drug therapy/*microbiology, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Community-Acquired Infections/diagnosis/*drug therapy/*microbiology, Comorbidity, Das Anita F, Department of Internal Medicine, Drug Resistance, Female, Fernandes Prabhavathi, File Thomas M Jr, Fluoroquinolones/*administration & dosage/adverse effects, Gonong Joven Roque V, Humans, Intravenous, Jamieson Brian D, Keedy Kara, Macrolides/*administration & dosage/adverse effects, Male, Microbial Sensitivity Tests, Middle Aged, Moxifloxacin, NEOMED College of Medicine, Oldach David, Oral, Pneumonia, Rewerska Barbara, Sheets Amanda, Taylor David, Treatment Outcome, Triazoles/*administration & dosage/adverse effects, Vucinic-Mihailovic Violeta
New recommendations for the treatment of tuberculosis.
Tags: 2005, Adult, Antitubercular Agents – Administration and Dosage, Antitubercular Agents – Adverse Effects, Antitubercular Agents – Pharmacodynamics, Antitubercular Agents – Therapeutic Use, Antitubercular Agents/adverse effects/pharmacology/*therapeutic use, Bacterial, Chemical and Drug Induced Liver Injury, Child, Current opinion in infectious diseases, Department of Internal Medicine, Drug Resistance, Female, Hepatitis, HIV Infections – Complications, HIV Infections/complications, Humans, Infant, Microbial, Multiple, Myers Joseph P, NEOMED College of Medicine, Practice Guidelines, Practice Guidelines as Topic, Preschool, Prescribing Patterns – Standards, Tuberculin Test, Tuberculosis – Drug Therapy, Tuberculosis – Epidemiology, Tuberculosis – Prevention and Control, Tuberculosis/*drug therapy/epidemiology/prevention & control, United States
Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia.
Tags: 2006, Anti-Infective Agents/*therapeutic use, Bacterial, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Community-Acquired Infections/*drug therapy/economics/*microbiology, Department of Internal Medicine, Drug Resistance, File T M Jr, Fluoroquinolones/*therapeutic use, Humans, Ketolides/therapeutic use, Multiple, NEOMED College of Medicine, Pneumococcal/*drug therapy/economics/*microbiology, Pneumonia, Streptococcus pneumoniae/*growth & development
Physical map of the tolC-htrP region of the Escherichia coli chromosome.
Tags: *Chromosome Mapping, *Chromosomes, *Escherichia coli Proteins, *Intramolecular Transferases, 1992, Bacterial, Bacterial Outer Membrane Proteins/genetics, Bacterial Proteins/*genetics, Deoxyribonucleases, Depew R E, Escherichia coli/*genetics, Heat-Shock Proteins, Journal of bacteriology, Membrane Transport Proteins, Molecular Sequence Data, Restriction Mapping, Type II Site-Specific/metabolism, Yang T P
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Tags: 2004, Bacterial, Bacterial/*drug therapy, Blasi Francesco, Canada, Chest, Chidiac Christian, Community-Acquired Infections/drug therapy, Department of Internal Medicine, Drug Resistance, Europe, File Thomas M Jr, Fluoroquinolones/therapeutic use, Garau Javier, Humans, Klugman Keith, Lactams/therapeutic use, Lode Hartmut, Lonks John R, Macrolides/therapeutic use, Mandell Lionel, NEOMED College of Medicine, Pneumonia, Practice Guidelines as Topic, Ramirez Julio, United States, Yu Victor
The science of selecting antimicrobials for community-acquired pneumonia (CAP).
Tags: *Drug Resistance, 2009, Anti-Bacterial Agents/*therapeutic use, Bacterial, Bacterial/*drug therapy, beta-Lactams/*therapeutic use, Chlamydophila pneumoniae/isolation & purification, Combination, Community-Acquired Infections/drug therapy, Department of Internal Medicine, Drug Therapy, File Thomas M, Fluoroquinolones/*therapeutic use, Humans, Journal of managed care pharmacy : JMCP, Legionnaires' Disease/drug therapy, Macrolides/*therapeutic use, Microbial Sensitivity Tests, NEOMED College of Medicine, Pneumonia, Practice Guidelines as Topic, Streptococcus pneumoniae/isolation & purification
International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
Tags: 2003, Adjuvants, Adult, Anti-Infective Agents/*therapeutic use, Bacterial, Bacterial/*drug therapy/microbiology, Clinical Trials as Topic, Community-Acquired Infections/drug therapy/microbiology, Department of Internal Medicine, Drug Resistance, Drugs, File Thomas M Jr, Humans, Immunologic/pharmacology/therapeutic use, Inpatients, Macrolides/pharmacology/*therapeutic use, Microbial Sensitivity Tests, NEOMED College of Medicine, Outpatients, Pneumonia, Practice Guidelines as Topic, Tan James S, Treatment Failure
Solutions to the problem of bacterial resistance.
Tags: *Drug Resistance, *Practice Guidelines as Topic, 2005, Anti-Bacterial Agents/*therapeutic use, Bacterial, Department of Internal Medicine, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Prescriptions/standards, Drug Utilization, File Thomas M Jr, Humans, NEOMED College of Medicine, Professional Practice/*standards, Treatments in respiratory medicine, Unnecessary Procedures
Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting.
Tags: 2007, Bacterial, Cleveland Clinic journal of medicine, Community-Acquired Infections/epidemiology/microbiology/*prevention & control, Cross Infection/epidemiology/microbiology/*prevention & control, Department of Internal Medicine, DNA, File Thomas M Jr, Hospitals, Humans, Infection Control, Methicillin Resistance/*genetics, NEOMED College of Medicine, Staphylococcal Infections/drug therapy/epidemiology/*prevention & control, Staphylococcus aureus/*drug effects/genetics
[Clinical impact of appropriate use of antibiotic in hospital according to CARAT criteria].
Tags: *Drug Resistance, *Guideline Adherence, *Practice Guidelines as Topic, 2008, Anti-Bacterial Agents/pharmacology/*therapeutic use, Bacterial, Bacterial Infections/drug therapy/epidemiology, Clinical Trials as Topic, Department of Internal Medicine, Drug Utilization, Europe/epidemiology, Evidence-Based Medicine, File Thomas M Jr, Hospitals/*standards, Humans, Intensive Care Units, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive, Multiple, NEOMED College of Medicine, Organizational Policy, Patients' Rooms
Using Procalcitonin to Differentiate Bacterial from Viral Meningitis.
Treating CAP caused by penicillin-resistant S pneumoniae.
Community-acquired pneumonia.
Tags: 2003, Antibiotics – Therapeutic Use, Bacterial, Bacterial – Diagnosis, Bacterial – Drug Therapy, Bacterial – Microbiology, Bacterial – Prevention and Control, Community-Acquired Infections, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Community-Acquired Infections – Prevention and Control, Department of Internal Medicine, Disease Progression, Drug Resistance, File T M Jr, Immunocompetence, Lancet, Microbial, NEOMED College of Medicine, Pneumonia, Severity of Illness, Streptococcus – Drug Effects, Vaccines – Therapeutic Use
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
Tags: 2012, a h1n1 virus, Antibacterial agents, Antiviral agents, asian influenza, Babinchak T, bacteremic pneumococcal, Bacterial, Community-acquired pneumonia, File T M, hong-kong influenza, Human, Infectious Diseases, Influenza, Influenza A, International Journal of Infectious Diseases, Journal Article or Conference Abstract Publication, Lode H, Masterton R G, Metersky M L, pandemic, Pneumonia, pregnant-women, randomized controlled-trial, respiratory-tract, streptococcus-pneumoniae, virus
230. Molecular Typing of Streptococcus pyogenes Isolates Collected at Mongolian Hospital (Ulaanbaatar, Mongolia).
Tags: 2019, antibiotic resistance, antimicrobial susceptibility, Bacterial, CENTERS for Disease Control & Prevention (U.S.), China, clone cells, Communicable Diseases, Davaadash Bulgan, Disclosure, Disease Outbreaks, DRUG resistance in bacteria, Epidemiology, Genes, ichthyosis, Infection, Journal Article, Kadariya Jhalka, low income, LOW-income countries, Mackey Samantha, Medical, Molecular, MOLECULAR epidemiology, Mongolia, Morbidity, Mortality, multi-antibiotic resistance, NEOMED College of Medicine Student, NEOMED Student Publications, November 2019 Update, Open forum infectious diseases, Polymerase Chain Reaction, sequence tagged sites, Smith Tara, sodium thiosulfate, Streptococcus pyogenes, surveillance, Thapaliya Dipendra, TOXIC shock syndrome, ULAANBAATAR (Mongolia), vaccine development, x-linked